Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ)
CNY 10.74
(0.0%)
CNY 10.74
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 346.2 Million CNY | -20.18% |
| 2022 | 374.26 Million CNY | -15.58% |
| 2021 | 443.32 Million CNY | 14.26% |
| 2020 | 388 Million CNY | -25.23% |
| 2019 | 518.91 Million CNY | 3.59% |
| 2018 | 500.95 Million CNY | 1.47% |
| 2017 | 493.7 Million CNY | 7.72% |
| 2016 | 458.3 Million CNY | 37.74% |
| 2015 | 332.71 Million CNY | 38.17% |
| 2014 | 240.8 Million CNY | 15.05% |
| 2013 | 209.3 Million CNY | 4.52% |
| 2012 | 200.24 Million CNY | 18.65% |
| 2011 | 168.77 Million CNY | 17.02% |
| 2010 | 144.22 Million CNY | 32.73% |
| 2009 | 108.66 Million CNY | 35.29% |
| 2008 | 80.32 Million CNY | 41.79% |
| 2007 | 56.64 Million CNY | 55.62% |
| 2006 | 36.4 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 78.76 Million CNY | -19.87% |
| 2024 Q2 | 98.29 Million CNY | 65.83% |
| 2024 Q1 | 59.27 Million CNY | 445.54% |
| 2023 Q4 | -17.15 Million CNY | -121.12% |
| 2023 Q1 | 161.58 Million CNY | 94.59% |
| 2023 FY | 298.73 Million CNY | -20.18% |
| 2023 Q3 | 81.22 Million CNY | 11.15% |
| 2023 Q2 | 73.07 Million CNY | -54.78% |
| 2022 Q2 | 76.82 Million CNY | -49.08% |
| 2022 FY | 374.26 Million CNY | -15.58% |
| 2022 Q1 | 150.87 Million CNY | 418.59% |
| 2022 Q4 | 83.03 Million CNY | -10.3% |
| 2022 Q3 | 92.57 Million CNY | 20.5% |
| 2021 Q2 | 272.61 Million CNY | 347.47% |
| 2021 Q3 | 26.47 Million CNY | -90.29% |
| 2021 Q1 | 60.92 Million CNY | 108.73% |
| 2021 FY | 443.32 Million CNY | 14.26% |
| 2021 Q4 | -47.35 Million CNY | -278.86% |
| 2020 Q4 | -697.52 Million CNY | -602.14% |
| 2020 FY | 388 Million CNY | -25.23% |
| 2020 Q1 | 69.48 Million CNY | 207.02% |
| 2020 Q2 | 164.93 Million CNY | 137.39% |
| 2020 Q3 | 138.91 Million CNY | -15.78% |
| 2019 Q3 | 88.37 Million CNY | -57.44% |
| 2019 Q4 | -64.92 Million CNY | -173.46% |
| 2019 FY | 518.91 Million CNY | 3.59% |
| 2019 Q1 | 149.48 Million CNY | 78.09% |
| 2019 Q2 | 207.66 Million CNY | 38.92% |
| 2018 Q4 | 83.93 Million CNY | -8.82% |
| 2018 Q3 | 92.05 Million CNY | -49.02% |
| 2018 Q2 | 180.57 Million CNY | 25.06% |
| 2018 Q1 | 144.38 Million CNY | 6.97% |
| 2018 FY | 500.95 Million CNY | 1.47% |
| 2017 Q1 | 124.04 Million CNY | 8.2% |
| 2017 FY | 493.7 Million CNY | 7.72% |
| 2017 Q2 | 165.25 Million CNY | 33.21% |
| 2017 Q4 | 134.97 Million CNY | 94.43% |
| 2017 Q3 | 69.42 Million CNY | -57.99% |
| 2016 Q2 | 147.62 Million CNY | 38.95% |
| 2016 Q4 | 114.64 Million CNY | 27.7% |
| 2016 FY | 458.3 Million CNY | 37.74% |
| 2016 Q1 | 106.24 Million CNY | 31.29% |
| 2016 Q3 | 89.78 Million CNY | -39.18% |
| 2015 Q2 | 98.61 Million CNY | 42.17% |
| 2015 Q1 | 69.36 Million CNY | 42.44% |
| 2015 FY | 332.71 Million CNY | 38.17% |
| 2015 Q4 | 80.92 Million CNY | -3.45% |
| 2015 Q3 | 83.81 Million CNY | -15.01% |
| 2014 Q3 | 58.76 Million CNY | -21.6% |
| 2014 FY | 240.8 Million CNY | 15.05% |
| 2014 Q4 | 48.69 Million CNY | -17.13% |
| 2014 Q2 | 74.95 Million CNY | 28.35% |
| 2014 Q1 | 58.39 Million CNY | 23.69% |
| 2013 FY | 209.3 Million CNY | 4.52% |
| 2013 Q1 | 52.66 Million CNY | 14.55% |
| 2013 Q2 | 59.01 Million CNY | 12.07% |
| 2013 Q3 | 50.41 Million CNY | -14.57% |
| 2013 Q4 | 47.2 Million CNY | -6.36% |
| 2012 Q1 | 42.62 Million CNY | 7.5% |
| 2012 Q2 | 56.23 Million CNY | 31.93% |
| 2012 Q3 | 55.41 Million CNY | -1.45% |
| 2012 FY | 200.24 Million CNY | 18.65% |
| 2012 Q4 | 45.97 Million CNY | -17.04% |
| 2011 Q2 | 49.06 Million CNY | 43.23% |
| 2011 Q4 | 39.65 Million CNY | -13.42% |
| 2011 FY | 168.77 Million CNY | 17.02% |
| 2011 Q1 | 34.25 Million CNY | -0.16% |
| 2011 Q3 | 45.79 Million CNY | -6.67% |
| 2010 Q1 | 26.08 Million CNY | -6.86% |
| 2010 Q2 | 45.32 Million CNY | 73.74% |
| 2010 FY | 144.22 Million CNY | 32.73% |
| 2010 Q3 | 38.5 Million CNY | -15.04% |
| 2010 Q4 | 34.31 Million CNY | -10.88% |
| 2009 Q1 | 18.48 Million CNY | -11.62% |
| 2009 Q4 | 28 Million CNY | 4.54% |
| 2009 Q3 | 26.79 Million CNY | -24.28% |
| 2009 Q2 | 35.37 Million CNY | 91.41% |
| 2009 FY | 108.66 Million CNY | 35.29% |
| 2008 Q4 | 20.91 Million CNY | -10.75% |
| 2008 FY | 80.32 Million CNY | 41.79% |
| 2008 Q3 | 23.43 Million CNY | 0.0% |
| 2007 FY | 56.64 Million CNY | 55.62% |
| 2006 FY | 36.4 Million CNY | 0.0% |